16 February 2021 | News
This technology is an alternative therapy that eliminates germs by ‘lysis’ rather than by utilising toxic chemicals
Hygienelabs™ India has secured ground-breaking verification from The Therapeutic Goods Administration (TGA), Australia’s regulatory authority, that its new-technology disinfectant treatment can inactivate the COVID-19 virus and other germs on surfaces for up to 24hrs to 28 days per application.
It is the only product in Australia, and possibly worldwide, to have proven and certificated 28-day effectiveness against Coronavirus infection on surfaces.
The treatment has also been approved by delegated laboratories for use in the cabins of Airbus and Boeing airliners. Also, the Hygienelabs™ India disinfectant has been independently evaluated and certificated by Eurofins Environment Testing Australia Pty Ltd, a division of Eurofins Scientific, one of the world’s leading bioanalytical testing organisations, with some 800 laboratories in 50 countries.
Hygienelabs India has developed a technology that creates an invisible barrier on the skin and surfaces that inactivates germs, bacteria, fungi and algae upon contact.
This technology is an alternative therapy that eliminates germs by ‘lysis’ rather than by utilising toxic chemicals. They are widely acknowledged as one of the most advanced non-volatile, surface-bonded antimicrobials, safe for humans, animals, and plants in the world.
Their scientifically proven technology offers a variety of sanitisers which are a class apart:
Built with a transmission reduction vision, Hygienelabs™ India specialises in developing and sourcing technologies such as the COVID-19 virus to fight germs faced by the world today.
The prevalence of life-threatening diseases has triggered the need for advanced hygiene and sanitation solutions.